Home/Pipeline/Mitochondrial Thermogenesis Activator

Mitochondrial Thermogenesis Activator

Obesity / Metabolic Disorders

Pre-clinicalActive

Key Facts

Indication
Obesity / Metabolic Disorders
Phase
Pre-clinical
Status
Active
Company

About Equator Therapeutics

Equator Therapeutics is pioneering a novel approach to obesity and metabolic disease by pharmacologically stimulating mitochondrial thermogenesis, a natural calorie-burning process. The company's core technology platform enables the direct measurement and high-throughput screening of compounds that activate specific mitochondrial proteins to induce heat production. With a strong scientific foundation published in top-tier journals and an experienced leadership team, Equator is advancing a pre-clinical pipeline with the potential to address a massive, underserved market. The company is a private, pre-revenue biotech positioned at the intersection of mitochondrial biology and metabolic therapeutics.

View full company profile

Other Obesity / Metabolic Disorders Drugs

DrugCompanyPhase
Oral Non-Incretin Small MoleculeAlaunos TherapeuticsPreclinical